Open Orphan #ORPH – New Contract win for Open Orphan’s Breda office

Open Orphan (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces a new contract win of c. €900,000 with an existing customer for clinical trial management by our Breda, Netherlands office. Cathal Friel, Executive Chairman of Open […]
Open Orphan #ORPH – World’s first Covid-19 human challenge study to expand

Open Orphan (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan plc, is continuing to work with the UK Government to inoculate up to 20 further volunteers as part of the […]
Blencowe Resources #BRES – Placing to Raise £235,000

Blencowe Resources, the natural resources company focussed on the development of the Orom-Cross Graphite Project in Uganda, is pleased to announce that it has raised £235,000 in a placing at 6 pence per share through the issue of 3,925,000 new ordinary shares (“Placing”). Also, the placees will receive one warrant per every two placing share […]
Kavango Resources #KAV Raises £31,250 in warrant exercise

Exercise of Warrants Kavango announces it has received notices to exercise warrants over 1,250,000 new ordinary shares of 0.001 each in the Company (the “Warrant Shares”). The Warrant Shares are being issued pursuant to the exercise of warrants granted on 1 December 2020. Subscription monies of £31,250.00 have been received by Kavango in respect of these exercises. Admission […]
Kavango Resources #KAV – Exercise of Warrants and Total Voting Rights

Exercise of Warrants Kavango announces it has received notices to exercise warrants over 250,000 new ordinary shares of 0.001 each in the Company (the “Warrant Shares”). The Warrant Shares are being issued pursuant to the exercise of warrants granted on 1 December 2020. Subscription monies of £10,625.00 have been received by Kavango in respect of these exercises. Admission […]
Alan Green discusses the upcoming Zenova Group #ZED IPO, plus Mosman Oil & Gas #MSMN & Karelian Diamonds #KDR on Vox Markets podcast

Alan Green discusses the upcoming Zenova Group #ZED IPO, plus Mosman Oil & Gas #MSMN & Karelian Diamonds #KDR with Justin Waite on the Vox Markets podcast
Alan Green discusses Conroy Gold #CGNR & Union Jack Oil #UJO on his weekly Stockbox Media Research talk

Alan Green discusses Conroy Gold #CGNR & Union Jack Oil #UJO on his weekly Stockbox Media Research talk
Mosman Oil & Gas #MSMN – Alan Green talks to Executive Chairman John Barr

Alan Green talks to John Barr, Executive Chairman at Mosman Oil & Gas #MSMN about the oil assets in production and development in Texas, plus the strategic helium assets in the Amadeus Basin, Northern Territories, Australia. John discusses the Falcon-1 well before moving onto the assets now owned by Mosman following the Nadsoilco acquisition. We […]
Power Metal Resources #POW – Golden Metal Resources Nevada Presentation Released Highlighting Exploration Potential of the Recently acquired Projects Located in Mining Friendly Nevada

Power Metal Resources plc (LON:POW), the AIM listed metals exploration and development company has prepared an information presentation covering the recently acquired Golconda Summit, Garfield, and Stonewall Projects (collectively the “Projects”) all located in mining friendly Nevada, USA. This information presentation may be viewed through the following link: https://www.powermetalresources.com/presentation/golden-metal-resources-presentation/ The Nevada Projects are held by […]
Open Orphan #ORPH – Significant HRV & Influenza human challenge study contract win

Open Orphan (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan plc, has signed a significant contract with AIM ImmunoTech Inc (“AIM IT”) to test its antiviral candidate, Ampligen, using both […]